EMBED CODE (Copy and Paste)
BENEFITS OF DOCUMENT
The colorectal cancer therapy market will grow modestly from $8.4 billion in 2015 to $12.5 billion in 2025 in the seven major pharmaceutical markets under study. Growth will be fueled by continued uptake of premium-priced therapies and the approval of six emerging therapies. In 2025, immune checkpoint inhibitors will hold an impressive 33% share of this market.
Got a question about the product? Email us at [email protected] or ask the author directly by using the form to the right. If you cannot view the preview above this document description, go here to view the large preview instead.
Source: Market Overview: Colorectal Cancer PDF document
Market Overview: Colorectal Cancer
This business document is categorized under the function(s): Health & Safety
It applies to Healthcare & Life Sciences.
File Size: 1.7 MB
Number of Pages: 26
Purchase includes lifetime product updates. After your purchase, you will receive an email to download this document.
Initial upload date (first version): Mar 8, 2017
Ask the Author a Question
Log In Below
Report this Document
Please explain why the content is inappropriate and provide as much detail as possible. Possible reasons include, but are not limited, to the following:
Are you a business professional?
Just as the mobile apps market has helped software developers earn sustainable, passive income, we hope Flevy will do the same for business professionals, like yourself. There's no reason to let your IP collect dust when it can be making you perpetual income.
CUSTOMERS ALSO BOUGHT THESE DOCUMENTS